The 70 rating InvestorsObserver gives to Beam Therapeutics Inc (BEAM) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 88 percent of stocks in the Biotechnology industry, BEAM’s 70 overall rating means the stock scores better than 70 percent of all stocks.
BEAM has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on BEAM!